Grifols

Grifols GIFLF Stock

$12.72   0.000000%
Add to favorites
Market Cap
$8.66B
LOW - HIGH [24H]
$11.69 - $11.69
VOLUME [24H]
$50.00
P/E Ratio
15.32
Earnings per share
$0.83
ISIN
ES0171996087
Price   Prediction

Grifols Price Chart

Sorry, that's all we've gotfor now...

Grifols (GIFLF) stock price today is 12.72 USD on OTC Markets OTCPK (0% on the day). Updated .

Grifols GIFLF Financial and Trading Overview

Grifols stock price 12.72 USD
Previous Close 12.72 USD
Open 11.69 USD
Bid 12.38 USD x 10000
Ask 13.07 USD x 10000
Day's Range 11.69 - 11.69 USD
52 Week Range 10.13 - 13.9 USD
Volume 50 USD
Avg. Volume 767 USD
Market Cap 8.66B USD
Beta (5Y Monthly) 1.132
PE Ratio (TTM) 15.325302
EPS (TTM) 0.83 USD
Forward Dividend & Yield 0.09 (0.73%)
Ex-Dividend Date December 2, 2026
1y Target Est N/A

GIFLF Valuation Measures

Enterprise Value 19.87B USD
Trailing P/E 15.325302
Forward P/E N/A
PEG Ratio (5 yr expected) 0.24
Price/Sales (ttm) 1.1395247
Price/Book (mrq) 1.3312838
Enterprise Value/Revenue 2.615
Enterprise Value/EBITDA 11.442

Trading Information

Grifols Stock Price History

Beta (5Y Monthly) 1.132
52-Week Change -8.48%
S&P500 52-Week Change 10.51%
52 Week High 13.9 USD
52 Week Low 10.13 USD
50-Day Moving Average 11.33 USD
200-Day Moving Average 11.31 USD

GIFLF Share Statistics

Avg. Volume (3 month) 767 USD
Avg. Daily Volume (10-Days) 20 USD
Shares Outstanding 422.36M
Float 418.22M
Short Ratio N/A
% Held by Insiders 31.19%
% Held by Institutions 41.36%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield 134.00%
Payout Ratio 0.1157
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 6.43%
Operating Margin (ttm) 18.85%
Gross Margin 38.15%
EBITDA Margin 22.85%

Management Effectiveness

Return on Assets (ttm) 4.46%
Return on Equity (ttm) 7.33%

Income Statement

Revenue (ttm) 7.6B USD
Revenue Per Share (ttm) 11.16 USD
Quarterly Revenue Growth (yoy) 9.40%
Gross Profit (ttm) 2.9B USD
EBITDA 1.74B USD
Net Income Avi to Common (ttm) 489M USD
Diluted EPS (ttm) 0.83
Quarterly Earnings Growth (yoy) 27.60%

Balance Sheet

Total Cash (mrq) 486M USD
Total Cash Per Share (mrq) 0.71 USD
Total Debt (mrq) 9.24B USD
Total Debt/Equity (mrq) 112.1 USD
Current Ratio (mrq) 2.329
Book Value Per Share (mrq) 9.5546875

Cash Flow Statement

Operating Cash Flow (ttm) 1.12B USD
Levered Free Cash Flow (ttm) 194.45M USD

Profile of Grifols

Country United States
State N/A
City Barcelona
Address Parque Empresarial Can Sant Joan
ZIP 08174
Phone 34 935 71 22 00
Website https://www.grifols.com
Industry Drug Manufacturers - General
Sector(s) Healthcare
Full Time Employees 25000

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Q&A For Grifols Stock

What is a current GIFLF stock price?

Grifols GIFLF stock price today per share is 12.72 USD.

How to purchase Grifols stock?

You can buy GIFLF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Grifols?

The stock symbol or ticker of Grifols is GIFLF.

Which industry does the Grifols company belong to?

The Grifols industry is Drug Manufacturers - General.

How many shares does Grifols have in circulation?

The max supply of Grifols shares is 680.58M.

What is Grifols Price to Earnings Ratio (PE Ratio)?

Grifols PE Ratio is 15.32530200 now.

What was Grifols earnings per share over the trailing 12 months (TTM)?

Grifols EPS is 0.83 USD over the trailing 12 months.

Which sector does the Grifols company belong to?

The Grifols sector is Healthcare.

$2.18T
Total marketcap
$71.41B
Total volume
BTC 58.24%   •   ETH 9.87%
Dominance
Select currency